-- 根據FactSet調查的分析師報告，Regeneron Pharmaceuticals (REGN) 的平均評級為“增持”，平均目標價為880.77美元。 （報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們：https://www..com/contact-us）
Price: $706.12, Change: $+19.76, Percent Change: +2.88%
Related Articles
Sectors
Sector Update: Financial
Financial stocks were higher late Thursday afternoon, with the NYSE Financial Index rising 1.3% and the State Street Financial Select Sector SPDR ETF (XLF) up 0.5%.The Philadelphia Housing Index climbed 1.6%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) added 1.5%.Bitcoin (BTC-USD) rose 0.9% to $76,409, and the yield for 10-year US Treasuries decreased 2.8 basis points to 4.39%.In corporate news, AvalonBay Communities (AVB) and Equity Residential (EQR) have held discussions over a potential merger, which would be one of the biggest real estate deals ever, Bloomberg reported. AvalonBay shares were down 1.1%, and Equity Residential was fractionally lower.
$AVB$EQR
Sectors
Sector Update: Health Care
Health care stocks rose late Thursday afternoon with the NYSE Health Care Index climbing 2.6% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 2.3%.The iShares Biotechnology ETF (IBB) advanced 1.9%.In corporate news, UniQure (QURE) shares jumped past 16% after the company said it plans to submit a UK marketing authorization application in Q3 for AMT-130 to treat Huntington's disease.
$QURE
Sectors
Sector Update: Consumer
Consumer stocks rose late Thursday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) rising 1.7% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) adding 1.5%.In corporate news, O'Reilly Automotive (ORLY) shares gained 7.7% on Thursday, a day after it reported higher-than-expected Q1 results.
$ORLY